Vimarsana
Biggest News Aggregation in the World

Page 12 - Murrays Kessler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Murrays Kessler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Murrays Kessler Today - Breaking & Trending Today

Perrigo Company PLC (PRGO) Q1 2021 Earnings Call Transcript - Vimarsana News

Perrigo Company PLC (PRGO) Q1 2021 Earnings Call Transcript

Hello and welcome to the Perrigo First Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference over to Bradley Joseph. Mr. Joseph, please go ahead. Bradley Joseph -- Vice President, Global Investor Relations and Corporate Communications Thank you and good morning, everybody, and welcome to Perrigo's first quarter fiscal 2021 earnings conference call. I hope you all had a chance to review the press release we issued earlier this morning. A copy of the earnings release and presentation for today's discussion are available within the Inves...

Source: fool.com
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration - Vimarsana News

Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration

Share this article Share this article DUBLIN, March 1, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for total consideration of $1.55 billion, including $1.5 billion in cash, subject to customary adjustments. As part of the consideration, Altaris will also assume more than $50 million in potential R&D milestone payments and contingent purchase obligations with third-party Rx partne...

Perrigo sells generics division for $1.55b to Altaris - Vimarsana News

Perrigo sells generics division for $1.55b to Altaris

Perrigo sells generics division for $1.55b to Altaris Perrigo will now have no activities in Israel. The sale threatens 850 jobs in the Negev and the company might delist from the TASE. Perrigo Company (NYSE:PRGO; TASE:PRGO) announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners LLC for $1.55 billion, including $1.5 billion in cash. As part of the consideration, Altaris will also assume more than $50 million in potential R&D milestone payments and contingent purchase obligations with third-party Rx partners. The d...

Perrigo Company (NASDAQ:PRGO) - Perrigo Divests Generic Pharma Business For $1.55B To Altaris Capital - Vimarsana News

Perrigo Company (NASDAQ:PRGO) - Perrigo Divests Generic Pharma Business For $1.55B To Altaris Capital

Perrigo Company Plc (NYSE: PRGO) has agreed to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners for $1.55 ...

PLMA gears up for online Private Label Week - Vimarsana News

PLMA gears up for online Private Label Week

With more than 700 exhibitors and 50 sessions, revamped event will be held Feb. 1-5 Pivoting from its annual in-person event and conference, the Private Label Manufacturers Association (PLMA) will kick off its first major online event for store brands in the U.S. on Monday, Feb. 1, for five days of back-to-back presentations and a virtual exhibit floor featuring more than 700 manufacturers. “PLMA Live! presents Private Label Week” will be streaming a daily schedule of original on-demand programming covering the latest marketing and consumer research, retail and private brand strateg...